Skip to nav Skip to content


September 18, 2019


Physicians Counter Truvada Safety Concerns

Responding to safety concerns that stemmed from an advertising campaign seeking lawsuit plaintiffs among people reporting serious side effects related to taking Truvada, the chairs of the HIV Medicine Association and the American Academy of HIV Medicine wrote this POZ opinion piece, encouraging people living with HIV to discuss their treatment options with their providers, and reinforcing the United States Preventive Services Task Force Grade A recommendation for Truvada for PrEP. This opinion piece in Positively Aware also addresses concerns raised by the advertising campaign and includes talking points for providers. Please consider sharing these resources with colleagues.

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.